Next report date
Report period
Q1 2024
EPS estimate
−1.20USD
Revenue estimate
73.47 MUSD
−239.24 MUSD
270.60 MUSD
38.78 M
Om Axsome Therapeutics, Inc.
Sektor
Bransch
VD
Herriott Tabuteau
Webbplats
Huvudkvarter
New York
Employees (FY)
545
Grundat
2012
FIGI
BBG00JVRN7V9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
